K

Kanchanalata

Director Director DIN 09081500
DIN 09081500 First appointment Feb 2021 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanchanalata

Data last updated:

Kanchanalata was a Director at Promed Biotech Private Limited (2023–2025) and Director at Justbeu Private Limited (from 2021). The companies operate in Trading.

DIN 09081500
Primary Designation Director
Industry Trading
First Appointment 25 Feb 2021
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Promed Biotech Private Limited U51909GJ2021PTC126799
Director13 Sep 20232021₹5.8 Lakh (FY 2025)Active
Justbeu Private Limited U52599UP2021PTC142438
Director25 Feb 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Justbeu Private Limited
Promed Biotech Private Limited
Premium access

Shareholding and investment profile for Kanchanalata

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanchanalata

Kanchanalata was first appointed on 25 Feb 2021 as Director at Justbeu Private Limited. The most recent appointment on record is 13 Sep 2023 at Promed Biotech Private Limited.

Kanchanalata held 2 earlier board appointments: Promed Biotech Private Limited (Director, 13 Sep 2023 to 23 Jan 2025); Justbeu Private Limited (Director, from 25 Feb 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available